Cargando…

Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees

In contrast to a second dose of the SARS-CoV-2 mRNA vaccine, a third dose elicits potent neutralizing activity against the Omicron variant. To address the underlying mechanism for this differential antibody response, we examined spike receptor-binding domain (RBD)–specific memory B cells in vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Takeshi, Shinnakasu, Ryo, Kawai, Chie, Yamamoto, Hiromi, Sakakibara, Shuhei, Ono, Chikako, Itoh, Yumi, Terooatea, Tommy, Yamashita, Kazuo, Okamoto, Toru, Hashii, Noritaka, Ishii-Watabe, Akiko, Butler, Noah S., Matsuura, Yoshiharu, Matsumoto, Hisatake, Otsuka, Shinya, Hiraoka, Kei, Teshima, Takanori, Murakami, Masaaki, Kurosaki, Tomohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750191/ https://www.ncbi.nlm.nih.gov/pubmed/36512034 http://dx.doi.org/10.1084/jem.20221786

Ejemplares similares

Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses
por: Shinnakasu, Ryo, et al.
Publicado: (2021)

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022)

The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help
por: Inoue, Takeshi, et al.
Publicado: (2017)

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees
por: Takahashi, Kenichiro, et al.
Publicado: (2022)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees
por: Anichini, Gabriele, et al.
Publicado: (2022)

Establishment of a highly precise multi-attribute method for the characterization and quality control of therapeutic monoclonal antibodies
por: Tajiri-Tsukada, Michiko, et al.
Publicado: (2020)

Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
por: Andreano, Emanuele, et al.
Publicado: (2022)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
por: Suzuki, Takuo, et al.
Publicado: (2021)

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
por: Yu, Pei, et al.
Publicado: (2023)

Adventitious viral genomes in vaccines but not in vaccinees.
por: Weiss, R A
Publicado: (2001)

Generation of High Quality Memory B Cells
por: Inoue, Takeshi, et al.
Publicado: (2022)

Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
por: Yadav, Pragya D., et al.
Publicado: (2022)

Exit from germinal center to become quiescent memory B cells depends on metabolic reprograming and provision of a survival signal
por: Inoue, Takeshi, et al.
Publicado: (2020)

Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation
por: Mileto, D., et al.
Publicado: (2022)

Comparison of Four T-cell Assays and Two Binding Antibody Assays in SARS-CoV-2 Vaccinees With or Without Omicron Breakthrough Infection
por: Seo, Yeon Ju, et al.
Publicado: (2023)

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
por: Dapporto, Francesca, et al.
Publicado: (2022)

Assessment of antibody responses against SARS-CoV-2 in unvaccinated individuals and vaccinees from Omicron-BA.2 infection in Zhaoqing, Guangdong Province, China
por: Zhang, Huan, et al.
Publicado: (2022)

PAtCh-Cap: input strategy for improving analysis of ChIP-exo data sets and beyond
por: Terooatea, Tommy W., et al.
Publicado: (2016)

Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
por: Kawasuji, Hitoshi, et al.
Publicado: (2023)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
por: Tada, Minoru, et al.
Publicado: (2015)

Impact of influenza vaccination in the Netherlands, 2007–2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees
por: Caini, Saverio, et al.
Publicado: (2021)

IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
por: Kang, Sujin, et al.
Publicado: (2020)

Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling
por: Kang, Sujin, et al.
Publicado: (2021)

Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
por: Aoyama, Michihiko, et al.
Publicado: (2019)

Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population()
por: Kawasuji, Hitoshi, et al.
Publicado: (2022)

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants
por: Leier, Hans C., et al.
Publicado: (2021)

Les taux de personnes vaccinées et non vaccinées contre le COVID-19 en France. Comparaison des indicateurs en open data et tentative d'estimation
por: Geay, C., et al.
Publicado: (2023)

Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages
por: Wang, Lei, et al.
Publicado: (2022)

CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes
por: Onodera, Taishi, et al.
Publicado: (2023)

Ability of History Taking Alone to Identify Early Pregnancies Among Potential Measles Vaccinees
por: Mead, Philip B.
Publicado: (1994)

Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees
por: Mateus, Jose, et al.
Publicado: (2020)

Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines
por: Flasche, Stefan, et al.
Publicado: (2019)

Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees
por: Oganezova, Karina, et al.
Publicado: (2020)

Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees
por: Garziano, Micaela, et al.
Publicado: (2022)

Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees
por: Asperti, Chiara, et al.
Publicado: (2022)

Waning of Antibody Response Among Vaccinees who Received Two Doses of Covishield Vaccine
por: Haritay, Shivani, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rc98ekaj4ekdi418uacjtbfdlk